Falk Ehmann
Impact in
- Immunology top 5%
- Biosimilars and Bioanalytical Methods
- Drug Discovery top 10%
Papers in
-
- Healthcare Regulation 13
- Physiology 15
- Biomedical Ethics and Regulation 14
- Co-authors
- Christian K. Schneider (5 shared papers)Marisa Papaluca (5 shared papers)Camille Vleminckx (4 shared papers)Martina Weise (4 shared papers)Kowid Ho (3 shared papers)Niklas Ekman (3 shared papers)Esa H. Heinonen (3 shared papers)Robin Thorpe (3 shared papers)
- Journals
- Nature Reviews Drug Discovery (5 papers)Frontiers in Medicine (4 papers)Clinical Pharmacology & Therapeutics (3 papers)Nature Biotechnology (3 papers)Blood (1 paper)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
Falk Ehmann
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Immunology 619
- Drug Discovery 6
- Pharmacology 190
- Biomaterials 124
- Health Information Management 62
Countries citing papers authored by Falk Ehmann
This map shows the geographic impact of Falk Ehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falk Ehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falk Ehmann more than expected).
Fields of papers citing papers by Falk Ehmann
This network shows the impact of papers produced by Falk Ehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falk Ehmann. The network helps show where Falk Ehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Falk Ehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 300 | |
| 2 | 2011 | 170 | |
| 3 | 2013 | 126 | |
| 4 | 2015 | 116 | |
| 5 | 2011 | 113 | |
| 6 | 2016 | 75 | |
| 7 | 2012 | 66 | |
| 8 | 2013 | 60 | |
| 9 | 2017 | 53 | |
| 10 | 2022 | 47 | |
| 11 | 2014 | 36 | |
| 12 | 2012 | 33 | |
| 13 | 2014 | 32 | |
| 14 | 2013 | 29 | |
| 15 | 2021 | 24 | |
| 16 | 2016 | 18 | |
| 17 | 2022 | 16 | |
| 18 | 2013 | 13 | |
| 19 | 2025 | 13 | |
| 20 | 2006 | 8 |
About Falk Ehmann
Falk Ehmann is a scholar working on Health Information Management, Physiology, Immunology, Statistics and Probability and Economics and Econometrics, having authored 35 papers that have together received 1.4k indexed citations. Recurring topics across this work include Biomedical Ethics and Regulation (14 papers), Healthcare Regulation (13 papers), Biosimilars and Bioanalytical Methods (9 papers), Pharmaceutical Economics and Policy (8 papers), Statistical Methods in Clinical Trials (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Immunology (619 citations), Drug Discovery (6 citations), Pharmacology (190 citations), Biomaterials (124 citations) and Health Information Management (62 citations). Falk Ehmann has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Christian K. Schneider, Marisa Papaluca, Camille Vleminckx, Martina Weise, Kowid Ho, Niklas Ekman, Esa H. Heinonen, Robin Thorpe, Karen De Smet and Gopalan Narayanan. Their work appears in journals such as Nature Reviews Drug Discovery, Frontiers in Medicine, Clinical Pharmacology & Therapeutics, Nature Biotechnology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.